Skip to content
Clinical Trials – home
IrelandBack to Ireland

Clinical trials in Sligo

12 clinical trials in Sligo, Ireland. Every trial is listed in the EU Clinical Trials Register and updated daily.

Sligo at a glance
12
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Sligo

Open in trial search

Study of ART27.13 for Patients with Cancer-Related Anorexia and Weight Loss

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Artelo Biosciences Limited

Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Psoriatic arthropathy

Not recruiting

Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Sjogren's syndrome

Not recruiting

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:VIB1116
  • Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ABCSG GmbH

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Breast cancer

Not recruiting

Study on the Effects of Chemotherapy and Endocrine Therapy in Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer Using Tamoxifen and Anastrozole

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Cancer Trials Ireland

Gastric cancer+5

Not recruiting

Study on Aspirin's Effect on Recurrence and Survival in Patients with Non-Metastatic Breast, Colon, Rectal, Stomach, Esophageal, and Prostate Cancer

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:University College London
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Argenx

Study on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Afimetoran Besilate Dihydrate

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Sligo

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on gynecologic cancers and maintenance therapies for various cancer types, including studies of novel combination treatments for ovarian cancer and multiple myeloma.

  • Ovarian, Fallopian Tube, and Peritoneal Cancers
  • Multiple Myeloma
  • Cancer-Related Weight Loss

Research includes groundbreaking studies on post-chemotherapy maintenance treatments and targeted therapies.

02 Breast Cancer Studies

Comprehensive research examining hormone receptor-positive breast cancer treatments, including studies on endocrine therapy and novel therapeutic combinations.

  • Early-Stage Breast Cancer
  • Adjuvant Therapy Optimization
  • Recurrence Prevention

Investigations focus on improving treatment outcomes and identifying optimal therapy combinations.

03 Autoimmune Disorders

Cutting-edge research on inflammatory conditions and autoimmune diseases, with particular emphasis on novel therapeutic approaches.

  • Systemic Lupus Erythematosus
  • Inflammatory Myopathy
  • Sjögren's Syndrome
  • Psoriatic Arthritis

Studies evaluate new biological treatments and their long-term safety profiles.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.